Hyelim Cho
Company: Takeda Pharmaceuticals
Job title: Group Lead, Immunogenicity
Seminars:
Immunogenicity & Antigenicity-Based T-Cell & Epitopes Identification for Design of Biologic Therapeutics 10:00 am
In silico analysis as an integrative approach for the assessment of immunogenicity in the pre-clinical phase In vitro validation study to offer predictive insights on immunogenicity of biotherapeutics Remaining challenges to offer better predictive insights to mitigate clinical immunogenicity risk of biotherapeuticsRead more
day: Day One